Lumexa Imaging Holdings, Inc. Common Stock (LMRI)
Raleigh, NC, US
Lumexa Imaging Holdings, Inc. manages and operates diagnostic imaging centers throughout the United States. These facilities deliver a comprehensive range of outpatient medical imaging solutions, encompassing advanced procedures like Magnetic Resonance Imaging (MRI), Computed Tomography (CT), and Positron Emission Tomography (PET) scans, in addition to standard diagnostic and screening services such as X-rays, ultrasounds, and mammography. The company was founded in 2018 and its primary base of operations is in Raleigh, North Carolina.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Metric |
Dec 2025 actual |
Dec 2026 6 Rev. Ana. 3 EPS Ana. |
Dec 2027 6 Rev. Ana. 4 EPS Ana. |
Dec 2028 4 Rev. Ana. 3 EPS Ana. |
Dec 2029 3 Rev. Ana. 1 EPS Ana. |
Dec 2030 3 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|
| Revenue |
1.02B
est: 1.02B (+0.7%)
|
1.07B
1.06B – 1.08B
+4.9% YoY
|
1.12B
1.11B – 1.13B
+5.5% YoY
|
1.19B
1.19B – 1.19B
+5.4% YoY
|
1.25B
1.24B – 1.27B
+5.9% YoY
|
1.32B
1.31B – 1.34B
+5.5% YoY
|
| EBITDA |
141.71M
est: 121.88M (+16.3%)
|
127.87M
126.68M – 129.07M
+4.9% YoY
|
134.87M
133.67M – 136.06M
+5.5% YoY
|
142.12M
142.12M – 142.12M
+5.4% YoY
|
150.44M
148.94M – 151.96M
+5.9% YoY
|
158.77M
157.19M – 160.37M
+5.5% YoY
|
| EBIT |
86.32M
est: 57.01M (+51.4%)
|
59.81M
59.25M – 60.37M
+4.9% YoY
|
63.08M
62.52M – 63.64M
+5.5% YoY
|
66.48M
66.48M – 66.48M
+5.4% YoY
|
70.37M
69.67M – 71.08M
+5.9% YoY
|
74.27M
73.53M – 75.01M
+5.5% YoY
|
| Net Income |
-47.10M
est: -10.26M (-359.1%)
|
52.74M
51.57M – 55.05M
+614.1% YoY
|
60.05M
59.02M – 61.08M
+13.9% YoY
|
74.35M
63.94M – 84.76M
+23.8% YoY
|
92.27M
91.08M – 93.48M
+24.1% YoY
|
103.63M
102.29M – 104.98M
+12.3% YoY
|
| SGA |
90.45M
est: 75.05M (+20.5%)
|
78.74M
78.01M – 79.48M
+4.9% YoY
|
83.05M
82.32M – 83.79M
+5.5% YoY
|
87.52M
87.52M – 87.52M
+5.4% YoY
|
92.64M
91.72M – 93.57M
+5.9% YoY
|
97.77M
96.80M – 98.76M
+5.5% YoY
|
| EPS |
-0.66
est: -0.14 (-372.9%)
|
0.76
0.73 – 0.78
+641.7% YoY
|
0.85
0.83 – 0.86
+12.6% YoY
|
1.06
0.90 – 1.19
+24.3% YoY
|
1.30
1.28 – 1.32
+22.9% YoY
|
1.46
1.44 – 1.48
+12.3% YoY
|
Owner Earnings
Owner's Earnings history not available.
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | F/M Emerald Life Sciences Innovation ETF LFSC | 0.92% | 689.3K | 0.54% |
| 2 | iShares Russell 2000 Value ETF IWN | 0.01% | 1.99M | 0.24% |
| 3 | iShares Morningstar Small Cap Value ETF ISCV | 0.01% | 81.6K | 0.06% |
| 4 | Vanguard Russell 2000 Value ETF VTWV | 0.01% | 130.0K | 0.06% |
| 5 | iShares Russell 2000 BuyWrite ETF IWMW | 0.01% | 4.3K | 0.39% |
| 6 | iShares Russell 2000 ETF IWM | 0.01% | 6.34M | 0.19% |
| 7 | iShares U.S. Small Cap Index ETF (CAD-Hedged) XSU.TO | 0.01% | 41.3K | 0.36% |
| 8 | Invesco Russell 2000 UCITS ETF RTYS.L | 0.01% | 23.2K | 0.25% |
| 9 | Global X - Russell 2000 ETF RSSL | 0.01% | 106.5K | 0.08% |
| 10 | Xtrackers Russell 2000 UCITS ETF 1C XRSU.L | 0.01% | 197.7K | 0.30% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for LMRI
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
